MUMBAI: The US generic drug industry, dominated by Indian companies, has found a surprising champion in former US Food and Drug Administration head Scott Gottlieb . I prescribed them to help my patients achieve value in their healthcare,” he tweeted on May 13. Today’s generic drug framework is vigilant and upholds FDA’s gold standard.” Nearly 90% of medicines that American patients take are non-branded generics. For one thing, the regulator’s oversight has vastly expanded, he said.In the past few years, the FDA has hired more than 1,000 people to work on generic drug issues. Recent audits of Indian companies have shown they can be compared with the best in the world and this is also the reason why exports to US have grown, Jain said.

Source: Economic Times May 16, 2019 01:41 UTC